Vector Laboratories, a Newark, CA-based pioneer of proteomic and glycomic research solutions, acquired Quanta BioDesign, the Plain City, OH-based inventor of discrete polyethylene glycol (dPEG®) technology for advanced bioconjugate and payload delivery design for life science and biopharma applications.
The amount of the deal was not disclosed.
This acquisition further expands Vector Laboratories’ portfolio of bioconjugation linkers and dyes and builds on its manufacturing and bioconjugation capabilities to serve partners across biopharma and the life sciences.
Led by Lisa V. Sellers, PhD, CEO, Vector Laboratories acquired Click Chemistry Tools, a manufacturer of click chemistry linkers and labeling reagents, and Fluoroprobes, a leader in fluorescent probes and dyes earlier this year. It is a portfolio company of Thompson Street Capital Partners.
Quanta BioDesign develops patented and innovative cross-linking and labeling chemistries that incorporate and are uniquely enabled by their dPEG® technology, allowing for new approaches in the areas of therapeutic and diagnostic development. The company was founded for the purpose of developing and commercializing an extensive line of dPEG® based products for companies involved in drug discovery and diagnostic development programs.
FinSMEs
25/07/2023